Guest Editors:
Shanquan Chen: The London School of Hygiene & Tropical Medicine, London, UK
Feng Sha: Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China
Zhirong Yang: Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong Province, China
BMC Medicine called for submissions to our Collection on Dementia prevention and therapies.
Dementia refers to syndrome associated with a decline in memory and neurocognitive function. The Global Dementia Observatory estimates that there are currently 55.2 million people living with some form of Dementia. Aging tends to be a major risk factor for development of Dementia with risk increasing from 1 in 14 for those aged over 65 to 1 in 6 for those over the age of 80. Partially because of individuals living longer lives this poses a major concern for society. As such the number of people living with Dementia are predicted to rise from 55 million to 139 million by the year 2050. This presents a major threat to health globally as recognised by the UN’s aim of 2021-2030 decade of improving the lives of older people. There is a clear need for a focus on interventions across the board which can help to address dementia progression.